About Us
About Guard Therapeutics
Vision, Business Model & Goal
The Board
Management
Research
Kidney disease
Science
Pipeline
RMC-035
GTX Peptides
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
Newsroom
Press releases
Event calender
Analyses and presentations
Subscribe
Contact
Swe
Search
Financial reports
Financial reports
Interim reports
2024
Interim report January-June 2024
Interim report January-March 2024
Other financial reports are currently only available in Swedish.